National Institutes of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the ...

A new State of Drug Access report shows that more than 40% of people living in the US could not afford their prescribed drugs ...

This patient perspectives interview features Stacy Courtnay, who shared her experience managing rheumatoid arthritis during pregnancy.

Fields, MD, FACP Rheumatoid arthritis (RA) is the most common ... A multipronged approach is essential for RA treatment, including patient education, nonpharmacologic therapy, pain medications (such ...

The biotech startup, a spinout of the University of Colorado Anschutz Medical Campus, launched this year with $15 million in ...

Adults with atopic dermatitis treated with upadacitinib had fewer major adverse cardiovascular events compared with ...

since some medications for RA seem to have a better chance of decreasing nodules than other treatments. Rheumatoid arthritis is caused by a problem with the immune system, which mistakes your own body ...

The first systematic genome-wide association study for pseudogout has identified two genes strongly associated with disease ...

A new Norwegian study has revealed that JAK inhibitors, commonly prescribed anti-inflammatory drugs, may significantly ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

A shocking new study out of Norway has revealed a popular class of medications can make it easier to catch Covid and the flu.

Earlier in this article I referred to the 'quasi-malignant' phenotype of rheumatoid arthritis. Our quest for managing earlier disease, and our evolving treatment strategies using drug combinations ...